Delayed-type hypersensitivity response to high doses of adenoviral vectors

Human Gene Therapy

Volumn 8, Issue 3, 1997, Pages 323-330

  Russi, Thomas J ^a   Hirschowitz, Edward A ^a   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; COMPLEMENTARY DNA; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HYDROCORTISONE; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; METHOTREXATE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DELAYED HYPERSENSITIVITY; FOOT PAD; GENE TRANSFER; GRANULOCYTE; HISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MONOCYTE; MOUSE; NONHUMAN; PROMOTER REGION; TRANSGENE;

ADENOVIRIDAE; ANIMALIA; CYTOMEGALOVIRUS;

EID: 0030879828     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.3-323     Document Type: Article

References (40)

1. AHMED, A.R., and BLOSE, D.A. (1983). Delayed-type hypersensitivity skin testing. A review. Arch. Dermatol. 119, 934-945.
2. CHER, D.J., and MOSMANN, T.R. (1987). Two types of murine helper T cell clone. H. Delayed-type hypersensitivity is mediated by Th1 clones. J. Immunol. 138, 3688-3694.
3. CHU, C.Q., FIELD, M., ANDREW, E., HASKARD, D., FELDMANN, M., and MAINI, R.N. (1992). Detection of cytokines at the site of tuberculin-induced delayed-type hypersensitivity in man. Clin. Exp. Immunol. 90, 522-529.
4. COOPER, M.G. (1972). Delayed-type hypersensitivity in the mouse. I. Induction and elicitation by salmonella adelaide flagellin and its derivatives. Scand. J. Immunol. 1, 167-178.
5. CRYSTAL, R.G., MCELVANEY, N.G., ROSENFELD, M.A., CHU, C.S., MASTRANGELI, A., HAY, J.G., BRODY, S.L., JAFFE, H.A., EISSA, N.T., and DANEL, C. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of the individuals with cystic fibrosis. Nature Genet. 8, 42-51.
6. DAI, Y., SCHWARZ, E.M., GU, D., ZHANG, W.-W., SARVETNICK, M., and VERMA, I.M. (1995). Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92, 1401-1405.
7. DVORAK, H.F., GALLI, S.J., and DVORAK, A.M. (1980). Expression of cell-mediated hypersensitivity in vivo - recent advances. Int. Rev. Exp. Pathol. 21, 119-194.
8. ENGELHARDT, J.F., YE, X., DORANZ, B., and WILSON, J.M. (1994). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.
9. FULLMER, M.A., SHEN, J.Y., MODLIN, R.L., and REA, T.H. (1987). Immunohistological evidence of lymphokine production and lymphocyte activation antigens in tuberculin reactions. Clin. Exp. Immunol. 67, 383-390.
10. GRAY, D.F., and JENNINGS, P.A. (1955). Allergy in experimental mouse tuberculosis. Am. Rev. Tuberc. 72, 171-195.
11. HERSH, J., CRYSTAL, R.G., and BEWIG, B. (1995). Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Ther. 2, 124-131.
12. HERZ, J., and GERARD, R.D. (1993). Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol in normal mice. Proc. Natl. Acad. Sci. USA 90, 2812-2816.
13. JAFFE, H.A., DANEL, C., LONGENECKER, G., METZGER, M., SETOGUCHI, Y., ROSENFELD, M.A., GANT, T.W., THORGEIRSSON, S.S., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., PAVIRANI, A., LECOCQ, J-P., and CRYSTAL, R.G. (1992). Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet. 1, 372-378.
14. JORDAN, W.S. (1958). Occurrence of adenovirus infections in civilian populations. Arch. Int. Med. 101, 54-59.
15. LAGRANGE, P.H., MACKANESS, G.B., and MILLER, T.E. (1974). Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J. Exp. Med. 139, 1529-1539.
16. LAGRANGE, P.H., TSIANG, H., HURTREL, B., and RAVISSE, P. (1978). Delayed-type hypersensitivity to rabies virus in mice: assay of active or passive sensitization by the footpad test. Infect. Immun. 21, 931-939.
17. LI, L., ELLIOTT, J.F., and MOSMANN, T.R. (1994). IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J. Immunol. 153, 3967-3978.
18. LI, Q., KAY, M.A., FINEGOLD, M., STRATFORD-PERRICAUDET, L.D., and WOO, S.L. (1993). Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4, 403-409.
19. MUHLHAUSER, J., JONES, M., YAMADA, I., CIRIELLI, C., LEMARCHAND, P., GLOE, T.R., BEWIG, B., SIGNORETTI, S., CRYSTAL, R.G., and CAPOGROSSI, M.C. (1996). Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient, recombinant adenovirus vectors. Gene Ther. 3, 145-153.
20. O'CALLAGHAN, J.W., BRETSCHER, P., and RUSSELL, A.S. (1986). The effect of low dose chronic intermittent parental methotrexate on delayed type hypersensitivity and acute inflammation in a mouse model. J. Rheumatol. 13, 710-714.
21. ROESSLER, B.J., ALLEN, E.D., WILSON, J.M., HARTMAN, J.W., and DAVIDSON, B.L. (1993). Adenoviral-mediated gene transfer to rabbit synovium in vivo. J. Clin. Invest. 92, 1085-1092.
22. ROSENFELD, M.A., SIEGFRIED, W., YOSHIMURA, K., YONEYAMA, K., FUKAYAMA, M., STIER, L.E., PAAKKO, P.K., GILARDI, P., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., JALLAT, S., PAVIRANI, A., LECOCQ, J-P., and CRYSTAL, R.G. (1991). Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 252, 431-434.
23. ROSENFELD, M.A., YOSHIMURA, K., TRAPNELL, B.C., YONEYAMA, K., ROSENTHAL, E.R., DALEMANS, W., FUKAYAMA, M., BARGON, J., STIER, L.E., STRATFORD-PERRICAUDET, L., PERRICAUDET, M., GUGGINO, W.B., PAVIRANI, A., LECOCQ, J-P., and CRYSTAL, R.G. (1992). In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143-155.
24. ROSENTHAL, A.S., and SHEVACH, E.M. (1976). The function of macrophages in T-lymphocyte antigen recognition. Contemp. Top. Immunobiol. 5, 47-90.
25. SETOGUCHI, Y., JAFFE, H.A., CHU, C.S., and CRYSTAL, R.G. (1994). Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation. Am. J. Respir. Cell Mol. Biol. 10, 369-377.
26. SMITH, R.H., and ZIOLA, B. (1986). Cyclophosphamide and dimethyl dioctadecyl ammonium bromide immunopotentiate the delayed-type hypersensitivity response to inactivated enveloped viruses. Immunology 58, 245-250.
27. SMITH, T.A.G., MEHAFFEY, M.G., KAYDA, D.B., SAUNDERS, J.M., YEI, S., TRAPNELL, B.C., MCCLELLAND, A., and KALEKO, M. (1993). Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genet. 5, 397-402.
28. THOMSON, A.W., MOON, D.K., and NELSON, D.S. (1983). Suppression of delayed-type hypersensitivity reactions and lymphokine production by cyclosporin A in the mouse. Clin. Exp. Immunol. 52, 599-606.
29. TRIPATHY, S.K., GOLDWASSER, E., LU, M.M., BARR, E., and LEIDEN, J.M. (1994). Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc. Natl. Acad. Sci. USA 91, 11557-11561.
30. +) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J. Immunol. 148, 2058-2061.
31. TURK, J.L. (1980). Delayed Hypersensitivity. (Elsevier/North-Holland Biomedical Press, Amsterdam) pp. 13-55.
32. VAN DIJK, H., BLOKSMA, N., RADEMAKER, P.M., SCHOUTEN, W.J., and WILLERS, J.M. (1979). Differential potencies of corticosterone and hydrocortisone in immune and immune-related processes in the mouse. Int. J. Immunopharmacol. 1, 285-292.
33. WHITTON, J.L., and OLDSTONE, A. (1996). Immune Response to Viruses. In Fields Virology. B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (Lippincott-Raven, Philadelphia) pp. 345-374.
34. + CTLs in vivo. J. Immunol. 155, 2564-2570.
35. YANG, Y., ERTL, H.C., and WILSON, J.M. (1994a). MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with El-deleted recombinant adenoviruses. Immunity 1, 433-442.
36. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONCZOL, E., and WILSON, J.M. (1994b). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
37. YANG, Y., LI, Q., ERTL, H.C., and WILSON, J.M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.
38. YEI, S., MITTEREDER, N., TANG, K., O'SULLIVAN, C., and TRAPNELL, B.C. (1994). Adenovirus-mediated gene transfer to cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Ther. 1, 192-200.
39. YEUNG, R.S., PENNINGER, J., and MAK, T.W. (1993). Genetically modified animals and immunodeficiency. Curr. Opin. Immunol. 5, 585-594.
40. ZABNER, J., PETERSEN, D.M., PUGA, A.P., GRAHAM, S.M., COUTURE, L.A., KEYES, L.D., LUKASON, M.J., ST GEORGE, J.A., GREGORY, R.J., SMITH, A.E., and WELSH, M.J. (1994). Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nature Genet. 6, 75-83.